LU90738I2 - Desloratadine - Google Patents

Desloratadine

Info

Publication number
LU90738I2
LU90738I2 LU90738C LU90738C LU90738I2 LU 90738 I2 LU90738 I2 LU 90738I2 LU 90738 C LU90738 C LU 90738C LU 90738 C LU90738 C LU 90738C LU 90738 I2 LU90738 I2 LU 90738I2
Authority
LU
Luxembourg
Prior art keywords
compound
properties
desloratadine
salts
anthihistaminic
Prior art date
Application number
LU90738C
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90738(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of LU90738I2 publication Critical patent/LU90738I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
LU90738C 1984-02-15 2001-03-09 Desloratadine LU90738I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58030484A 1984-02-15 1984-02-15

Publications (1)

Publication Number Publication Date
LU90738I2 true LU90738I2 (fr) 2001-05-09

Family

ID=24320550

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90738C LU90738I2 (fr) 1984-02-15 2001-03-09 Desloratadine

Country Status (12)

Country Link
US (1) US4659716A (fr)
EP (1) EP0152897B1 (fr)
JP (1) JPS61501205A (fr)
AT (1) ATE47140T1 (fr)
AU (1) AU570306B2 (fr)
DE (2) DE3573600D1 (fr)
DK (1) DK163059C (fr)
FI (1) FI82934C (fr)
HU (1) HU194864B (fr)
LU (1) LU90738I2 (fr)
NL (1) NL300042I2 (fr)
WO (1) WO1985003707A1 (fr)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208855B1 (fr) * 1985-05-13 1991-03-06 Schering Corporation Procédé de préparation de dihydrodibenzo(a,d)cycloheptènes pipéridylidène et leurs dérivés azotés, composés ainsi obtenus et leur utilisation dans la préparation de médicaments
US4804666A (en) * 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
US4873335A (en) * 1986-03-12 1989-10-10 Schering Corporation 3-phenethyl-2-benzene-amides or aza-derivatives thereof
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5438062A (en) * 1986-10-31 1995-08-01 Schering Corporation Benzo(5,6)cycloheptapyridines, compositions and methods of use
US5665726A (en) * 1986-10-31 1997-09-09 Schering Corporation Benzo[5,6]cycloheptapyridines, compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
ES2056214T3 (es) * 1988-04-28 1994-10-01 Schering Corp Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso.
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
ZA914764B (en) * 1990-06-22 1992-03-25 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use
ES2040177B1 (es) * 1992-03-06 1994-05-16 S A Tamarang Procedimiento para la sintesis de la 8-cloro-6, 11-dihidro-11, (1-etoxicarbonil-4-piperidiliden) -5h-benzo (5,6) ciclohepta-(1,2-b) piridina.
JPH07505393A (ja) * 1992-03-27 1995-06-15 シェリング・コーポレーション 非橋渡しビスアリールカルビノール誘導体，組成物および使用法
ES2102026T3 (es) * 1992-03-27 1997-07-16 Schering Corp Derivados de bis-aril-carbinol puenteados, composiciones y metodos de uso.
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US5998620A (en) * 1997-03-25 1999-12-07 Schering Corporation Synthesis of intermediates useful in preparing tricyclic compounds
EP0978281B1 (fr) * 1997-04-25 2002-07-17 Schering-Plough Kabushiki Kaisha Collyres contenant une metabolite de loratidine
US6506767B1 (en) 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
UA62976C2 (en) * 1997-07-02 2004-01-15 Schering Corp Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
US6140337A (en) 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
DK0968715T3 (da) * 1998-06-30 2004-12-27 Pfizer Prod Inc Loratadin til anvendelse som et antiarytmikum
CZ300843B6 (cs) * 1998-07-10 2009-08-26 Schering Corporation Stabilizovaný farmaceutický prostredek na bázi dekarbonylethoxyloratadinu
US6423721B1 (en) 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6271378B1 (en) 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
WO2001015668A1 (fr) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Formulation de type pastille a liberation controlee
PE20010673A1 (es) * 1999-09-21 2001-06-30 Schering Corp Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios
AU7589700A (en) * 1999-09-22 2001-04-24 Schering Corporation Treating allergic and inflammatory conditions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
WO2001045676A2 (fr) 1999-12-20 2001-06-28 Schering Corporation Composition de dose orale a liberation prolongee
WO2001045668A2 (fr) 1999-12-20 2001-06-28 Schering Corporation Composition de dose orale a liberation prolongee
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
AU3800601A (en) * 2000-02-03 2001-08-14 Schering Corporation Treating allergic and inflammatory conditions
WO2002058608A1 (fr) * 2000-10-23 2002-08-01 Euro-Celtique, S.A. Dispositif d'administration transdermique de loratadine et procedes d'utilisation
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
US20030053956A1 (en) * 2001-01-24 2003-03-20 Thomas Hofmann Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US6599913B1 (en) * 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6720002B2 (en) * 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
CA2457397A1 (fr) 2001-08-21 2003-02-27 Schering Corporation Procede de synthese d'un intermediaire de cetone tricyclique
WO2003086275A2 (fr) * 2002-04-15 2003-10-23 Sun Pharmaceutical Industries Limited Compose antihistaminique sensiblement pur
US20030004179A1 (en) * 2002-05-21 2003-01-02 Affrime Melton B Treating allergic and inflammatory conditions
AU2003248657A1 (en) * 2002-06-10 2003-12-22 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
GB0216383D0 (en) * 2002-07-13 2002-08-21 Astrazeneca Ab Compounds
PL374799A1 (en) * 2002-08-05 2005-10-31 Sandoz Ag Novel salt and polymorphs of desloratadine hemifumarate
AU2003287206A1 (en) * 2002-10-23 2004-05-13 Janssen Pharmaceutica, N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
ES2232331T1 (es) * 2003-03-12 2005-06-01 Biogal Gyogyszergyar Rt. Procedimientos para la preparacion de formas polimorficas de desloratadina.
WO2004080997A1 (fr) * 2003-03-13 2004-09-23 Morepen Laboratories Limited Procede de preparation de loratadine
JP2007532687A (ja) * 2004-04-26 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩酸塩の結晶形およびその製造方法
EP1817307A2 (fr) * 2004-07-07 2007-08-15 Egis Gyogyszergyar Rt. Nouveau pseudopolymorphe de desloratadine forme avec du dioxyde de carbone
WO2006006184A2 (fr) * 2004-07-08 2006-01-19 Morepen Laboratories Limited Procede de production de loratadine et ses intermediaires
NL1026634C2 (nl) * 2004-07-12 2006-01-16 Willem Jacob Van Der Burg Psychofarmaceutisch preparaat en werkzame stof daarin.
ZA200701036B (en) * 2004-07-16 2008-05-28 Cipla Ltd Anti-histaminic composition
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
US20070009558A1 (en) * 2004-12-22 2007-01-11 David Harris Sugar-free storage-stable antihistaminic syrups
US20070004671A1 (en) * 2005-05-20 2007-01-04 Agarwal Sudeep K Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US20070060756A1 (en) * 2005-08-11 2007-03-15 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of desloratadine
US20070135472A1 (en) * 2005-12-01 2007-06-14 Glenmark Pharmaceuticals Limited Novel crystalline forms of desloratadine and processes for their preparation
CA2541045A1 (fr) * 2006-03-24 2007-09-24 Pharmascience Inc. Composition pharmaceutique contenant de la decarbonylethoxyloratadine
EP2029114B1 (fr) * 2006-06-01 2014-09-24 Merck Sharp & Dohme Corp. Compositions pharmaceutiques pour la libération prolongée de phenylephrine
AR061169A1 (es) * 2006-06-01 2008-08-06 Schering Plough Healthcare Formulaciones farmaceuticas de fenilferina y composiciones para su absorcion en el colon
WO2007143382A2 (fr) * 2006-06-07 2007-12-13 Morton Grove Pharmaceuticals, Inc. Formulations de loratadine liquide pour voie orale et procédés
HU230417B1 (hu) * 2006-10-26 2016-05-30 Egis Gyógyszergyár Zrt Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
WO2008107777A2 (fr) * 2007-03-06 2008-09-12 Cadila Pharmaceuticals Limited Procédé amélioré de préparation de desloratadine comportant des taux réduits de solvants organiques
US20090054338A1 (en) * 2007-08-06 2009-02-26 Aberg A K Gunnar Synergisms between repartitioning and immunomodulating compounds
US20090082385A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched desloratidine
WO2010021681A2 (fr) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions et procédés pour le traitement de maladies virales
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
WO2010109442A1 (fr) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Procede de preparation de desloratadine
CA2764830A1 (fr) 2009-06-16 2010-12-23 Schering Corporation Nouveaux [3,2-c] heteroaryl steroides en tant qu'agonistes des recepteurs glucocorticoides, compositions et utilisations de ceux-ci
ATE525064T1 (de) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg Pharmazeutische zusammensetzung mit desloratadin
CA2690490C (fr) 2010-01-19 2012-06-26 Accucaps Industries Limited Formulations pharmaceutiques de loratadine pour encapsulation et combinaisons associees
EP2571485B1 (fr) 2010-05-18 2022-02-16 Mahmut Bilgic Formulations antihistaminiques effervescentes
DE102010044246B4 (de) 2010-09-02 2015-06-25 Johnson Controls Gmbh Kopfstütze mit zwei Flügelelementen und Verfahren zur Montage eines Flügelelementes
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009396A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US20140120121A1 (en) 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US20150272941A1 (en) 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US9138431B2 (en) 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
US10525057B2 (en) 2013-09-24 2020-01-07 Otsuka Pharmaceutical Co., Ltd. Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
CN104961724B (zh) * 2015-06-08 2018-01-30 惠州信立泰药业有限公司 一种获得高纯度地氯雷他定的先进生产工艺
RU2631619C2 (ru) * 2015-08-03 2017-09-25 Общество с ограниченной ответственностью "Трейдсервис" Диспергируемая в воде таблетка дезлоратадина и способ ее изготовления
CN107556237B (zh) * 2017-08-28 2020-11-24 四川大学 一种3-(2-苯乙基)-2-吡啶甲酰胺类化合物的制备方法
CN107400083A (zh) * 2017-08-28 2017-11-28 四川大学 一种3‑[2‑(3‑氯苯基)乙基]‑2‑吡啶甲腈的制备方法
CA3199160A1 (fr) 2020-12-04 2022-06-09 Cecilia Jannette Munoz Martinez Combinaison pharmaceutique d'un corticosteroide et d'un antihistaminique pour le traitement et la regulation du composant inflammatoire de processus allergiques
CN112898268A (zh) * 2021-04-07 2021-06-04 深圳振强生物技术有限公司 一种地氯雷他定杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (fr) * 1963-04-24
US3391143A (en) * 1966-05-16 1968-07-02 Smith Kline French Lab 9-piperidyl and 9-piperidylidene derivatives of acridan
US3717647A (en) * 1971-04-09 1973-02-20 Schering Corp Alpha-nicotinoyl phenylacetonitriles
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines

Also Published As

Publication number Publication date
WO1985003707A1 (fr) 1985-08-29
JPS61501205A (ja) 1986-06-19
EP0152897B1 (fr) 1989-10-11
DK469485D0 (da) 1985-10-14
NL300042I2 (nl) 2001-07-02
US4659716A (en) 1987-04-21
AU570306B2 (en) 1988-03-10
AU3993885A (en) 1985-09-10
FI82934C (fi) 1991-05-10
DK163059B (da) 1992-01-13
DK163059C (da) 1992-06-09
FI853675A0 (fi) 1985-09-25
DK469485A (da) 1985-10-14
ATE47140T1 (de) 1989-10-15
JPH0572910B2 (fr) 1993-10-13
HU194864B (en) 1988-03-28
NL300042I1 (nl) 2001-06-01
HUT38332A (en) 1986-05-28
DE3573600D1 (en) 1989-11-16
EP0152897A1 (fr) 1985-08-28
DE10199025I1 (de) 2001-08-02
FI853675L (fi) 1985-09-25
DE10199025I2 (de) 2004-04-01
FI82934B (fi) 1991-01-31

Similar Documents

Publication Publication Date Title
LU90738I2 (fr) Desloratadine
IE811328L (en) Antihistamine compounds
DK73193D0 (da) Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
KR960009426B1 (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo£5,6|cyclohepta-£1,2-b|pyridines
PL337712A1 (en) Polymorphous form of 8-chloro-6, 11-dihydro-11-94-piperydilene) -5h-benzo[5,6]cyclohepta [1,2-b] pyridine
DK1073438T3 (da) 8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions
ZA877919B (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridines and compositions and methods of use